Skip to main content

Advertisement

SpringerLink
Log in

Cystectomy for Benign Indications

  • Lower Urinary Tract Symptoms & Voiding Dysfunction (J Sandhu, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This article evaluates the historical influences, current use, surgical techniques, and recent evidence on outcomes for cystectomy performed for benign indications.

Recent Findings

At the population level, cystectomy for benign indications has similar perioperative morbidity to radical cystectomy for cancer. Postoperative patient satisfaction is high and functional outcomes appear good, including sexual function. Patient regret about diversion choice is low provided decisions are well informed.

Summary

Cystectomy is important both as a primary procedure for benign disease and as an adjunct to primary urinary diversion. Early morbidity remains high but long-term results are encouraging. Further studies are needed to guide patient decision-making, to help inform diversion choice, and to understand the long-term impact of surgery and diversion choice on quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Aisen CM, Lipsky MJ, Tran J, Chung DE. Understanding simple cystectomy for benign disease: a unique patient cohort with significant risks. J Urol. 2017;110:239–43. First population analysis of early cystectomy complications for 389 patients with benign vs 4,659 malignant indications. Overall 60.4% complications in benign cohort, not significantly different from RC for malignancy.

    Article  Google Scholar 

  2. • Erpelding SG, et al. Cystectomy for benign disease: readmission, morbidity, and complications. Can J Urol. 2018;25(5):9473–9.

    PubMed  Google Scholar 

  3. Chong JT, Dolat MT, et al. The role of cystectomy for non-malignant conditions: a review. Can J Urol. 2014;21(5):7433–41.

    PubMed  Google Scholar 

  4. Simon J. Operation for directing the ureteral orifices into the rectum, temporary success, subsequent death, autopsy. Lancet. 1852;2:568–70.

    Article  Google Scholar 

  5. Bovee JW. Total extirpation of the urinary bladder. Trans Am Gyn Soc. 1901;26:199–217.

    Google Scholar 

  6. De Forest HP. I. Chaput on the inosculation of the ureters with the intestine. Ann Surg. 1894;20(2):193–205.

  7. Verhoogen J. Neostomie uretero-cecale. Formation d’une poche vesicale et d’un noveau ure`tre. Assoc Franc d’Urol. 1908;12:352–65.

  8. Jewett H. A new method of ureteral transplantation for cancer of the bladder. J Urol. 1942;48(5):489–509.

    Article  Google Scholar 

  9. Marshall VF, Whitmore WF. Technique for extension of radical surgery in the treatment of vesical cancer. Cancer. 1949;2:424–8.

    Article  CAS  Google Scholar 

  10. Bricker EM. Bladder substitution after pelvic evisceration. Surg Clin North Am. 1950;30(5):1511–21.

    Article  CAS  Google Scholar 

  11. Kock NG, Nilson LE, et al. Urinary diversion via a continent ileal reservoir: clinical results in 12 patients. J Urol. 1982;128(3):469–75.

    Article  CAS  Google Scholar 

  12. Camey M. Bladder replacement by ileocystoplasty following radical cystectomy. World J Urol. 1985;3:161–6.

    Article  Google Scholar 

  13. Rowland RG, Mitchell ME, et al. Indiana continent urinary reservoir. J Urol. 1987;137(6):1136–9.

    Article  CAS  Google Scholar 

  14. Hautmann RE, Egghart G, Frohneberg D, Miller K. The ileal neobladder. J Urol. 1988;139(1):39–42.

    Article  CAS  Google Scholar 

  15. Rowley MW, Clemens JQ, Latini JM, Cameron AP. Simple cystectomy: outcomes of a new operative technique. J Urol. 2011;78:942–5.

    Article  Google Scholar 

  16. • Osborn DJ, Dmochowski RR, et al. Cystectomy with urinary diversion for benign disease: indications and outcomes. Urology. 2014;83:1433–7. 139 patients undergoing cystectomy for benign disease with median 13 month follow up, 57% had complications Clavien-Dindo Grade >= II, increased risk for longer operative time but not surgical approach or diversion choice.

    Article  Google Scholar 

  17. •• Brown ET, Osborn D, et al. Temporal trends in conduit urinary diversion with concomitant cystectomy for benign indications: a population-based analysis. Urology. 2016;98:70–4. First large-scale analysis of operative indications for 4,247 cystectomies performed at time of urinary diversion for benign indications. Cystectomy rate increased from 20% of diversions in 1998 to 35% in 2011.

    Article  Google Scholar 

  18. Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–53.

    Article  Google Scholar 

  19. Cox A, Golda N, Nadeau G, et al. CUA guideline: diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10(5–6):E136–55.

    Article  Google Scholar 

  20. Kavanagh A, Baverstock R, Campeau L, et al. Canadian urological association guideline: diagnosis, management and surveillance of neurogenic lower urinary tract dysfunction. Can Urol Assoc J. 2019;13(6):E157–76.

    PubMed  PubMed Central  Google Scholar 

  21. Fazili T, Bhat TR, et al. Fate of the leftover bladder after supravesical urinary diversion for benign disease. J Urol. 2006;176(2):620–1.

    Article  Google Scholar 

  22. Lawrence A, Hu B, Lee O, Stone A. Pyocystis after urinary diversion for incontinence: is a concomitant cystectomy necessary? Urology. 2013;82:1161–5.

    Article  Google Scholar 

  23. Peeker R, Aldernborg F, Fall M. The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J Urol. 1998;159:1479–82.

    Article  CAS  Google Scholar 

  24. Linn JF, Hohenfellner M, et al. Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution. J Urol. 1998;159:774–8.

    Article  CAS  Google Scholar 

  25. Finley DS, Lee U, et al. Urinary retention after orthotopic neobladder substitution in females. J Urol. 2011;186(4):1364–9.

    Article  Google Scholar 

  26. Cohn JA, Large MC, et al. Cystectomy and urinary diversion as management of treatment-refractory benign disease: the impact of preoperative urological conditions on perioperative outcomes. Int J Urol. 2014;21:382–6.

    Article  Google Scholar 

  27. Fahmy O, Khairul-Asri MG, et al. Clincopathological features and prognostic value of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens: a systematic review and meta-analysis of 13,140 patients. J Urol. 2017;197(2):385–90.

    Article  Google Scholar 

  28. • Brown ET, Osborn D, et al. Perioperative complications of conduit urinary diversion with concomitant cystectomy for benign indications: a population-based analysis. Neurourol Urodyn. 2017;36(5):1411–6. Follow-on study adding perioperative complications to prior report on 4,247 cystectomies, overall complication rate 35% if concomitant cystectomy performed during urinary diversion (OR=1.23 vs diversion without cystectomy).

    Article  Google Scholar 

  29. • Al Hussein Al Awamlh B, Lee DJ, et al. Assessment of the quality-of-life and functional outcomes in patients undergoing cystectomy and urinary diversion for the management of radiation-induced refractory benign disease. Urology. 2015;85:394–401. Effect of cystectomy on healthcare-related quality of life (SF-36v2) for 19 patients with refractory benign sequelae of prior radiation. Average improvements 14 points in physical domains, 38 points in mental domains (range: 0-100 for both).

  30. Krebs J, Bartel P, Pannek J. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction. Neurourol Urodyn. 2016;35(2):260–6.

    Article  Google Scholar 

  31. ‘t Hoen L, Ecclestone H, et al. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: a systematic review. Neurourol Urodyn. 2017;36(7):1685–702.

  32. • Veskimäe E, Neuzillet Y, et al. Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU Int. 2017;120(1):12–24. Review finding improved continence and sexual function after pelvic organ-preserving modifications to RC in women. These modified approaches often resemble subtrigonal approaches used in benign disease.

    Article  Google Scholar 

  33. Ali-El-Dein B, Mosbah A, et al. Preservation of the internal genital organs during radical cystectomy in selected women with bladder cancer: a report on 15 cases with long term follow-up. Eur J Surg Oncol. 2013;39(4):358–64.

    Article  CAS  Google Scholar 

  34. Bhatta Dhar N, Kessler TM, et al. Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients. Eur Urol. 2007;52(4):1006–14.

    Article  Google Scholar 

  35. Chantalat E, Vaysse C, et al. Anatomical description of the umbilical arteries and impact of their ligation on pelvic and perineal vascular supply after cystectomy in women. Surg Radiol Anat. 2018;40(7):729–34.

    Article  CAS  Google Scholar 

  36. •• Hernández V, Linares-Espinós E, et al. Oncological and functional outcomes of sexual function-preserving cystectomy compared with standard radical cystectomy in men: a systematic review. Urol Oncol. 2017;35(9):539.e17-539.e29. Includes continence and erectile function after several sexual functionpreserving (SFP) approaches to RC in men, with potency in 58–93.8% and daytime continence in 88.9–100% after SFP.

    Article  Google Scholar 

  37. Gotsadze DT, Chakvetadze VT, Danelia EV. Why and how to modify standard cystectomy. Urologiia. 2008;2:22–6.

    Google Scholar 

  38. Mertens LS, Meijer RP, et al. Prostate sparing cystectomy for bladder cancer: 20-year single center experience. J Urol. 2014;191(5):1250–5.

    Article  Google Scholar 

  39. Voskuilen CS, Fransen van de Putte E, et al. Prostate sparing cystectomy for bladder cancer: a two-center study. Eur J Surg Onc. 2018;44(9):1446–52.

  40. Abdelaziz AY, Shaker H, et al. Early oncological and functional outcomes of prostate capsule sparing cystectomy compared with standard radical cystectomy. Curr Urol. 2019;13(1):37–45.

    Article  Google Scholar 

  41. Lee RK, Abol-Enein H, et al. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection and outcomes. BJU Int. 2014;113(1):11–23.

    Article  Google Scholar 

  42. Pazeto CL, Baccaglini W, et al. HRQOL related to urinary diversion in radical cystectomy: a systematic review of recent literature. Int Braz J Urol. 2019;45(6):1094–104.

    Article  Google Scholar 

  43. • Check DK, Leo MC, et al. Decision regret related to urinary diversion choice among patients treated with cystectomy. J Urol. 2020;203(1):159–63. One hundred ninety-two patients were surveyed on regret of diversion choice at 6 and 18 months after RC. Regret did not differ between the ileal conduit and neobladder and decreased if pre-op decision-making was more highly informed.

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Kaiser Permanente Los Angeles Medical Center, 4900 Sunset Boulevard Fl 2, Los Angeles, CA, 90027, USA

    Owen P. Aftreth, Christopher F. Tenggardjaja & Polina Reyblat

Authors
  1. Owen P. Aftreth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher F. Tenggardjaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Polina Reyblat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Polina Reyblat.

Ethics declarations

Conflict of Interest

The authors have no conflicts of interest with this article.

Human and Animal Rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Lower Urinary Tract Symptoms & Voiding Dysfunction

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aftreth, O.P., Tenggardjaja, C.F. & Reyblat, P. Cystectomy for Benign Indications. Curr Urol Rep 23, 195–201 (2022). https://doi.org/10.1007/s11934-022-01100-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-022-01100-1

Keywords

Search

Navigation